Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Pick's disease, also known as Pick disease,or FTD is a rare fronto-temporal neurodegenerative disease. This study will investigate the use of far infrared radiation for the control, management and treatment of Pick's disease.
| Condition | Intervention | Phase |
|---|---|---|
|
Pick Disease of the Brain |
Radiation: Radiation: Far Infrared Radiation (5μm to 20μm wavelength) |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Management, Control and Treatment of Frontotemporal Dementia (Pick's Disease) |
- Therapy for FTD patients [ Time Frame: 1 year ] [ Designated as safety issue: No ]
- Rehabilitation of FTD Patients [ Time Frame: 1 Year ] [ Designated as safety issue: No ]
| Enrollment: | 0 |
| Study Start Date: | May 2008 |
| Estimated Study Completion Date: | October 2009 |
| Estimated Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
|
Radiation: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
Far Infrared Radiation (5μm to 20μm wavelength). Far Infrared radiation for 30 to 40 minutes per treatment session.
Other Name: Far Infrared Radiation (5μm to 20μm wavelength)
|
Detailed Description:
This disorder causes progressive destruction of nerve cells in the brain and causes tau proteins to accumulate into the "Pick bodies" that are a defining characteristic of the disease. Tau proteins are microtubule-associated proteins that are abundant in neurons in the central nervous system and are less common elsewhere.
Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells.
It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have FTD.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- People with Pick's Disease
Exclusion Criteria:
- None
Contacts and Locations| Canada, Ontario | |
| The Centre for Incurable Diseases | |
| Toronto, Ontario, Canada, M4V 1L5 | |
| Principal Investigator: | Ken Nedd, M.D. | GAAD Medical Research Institute Inc. |
More Information
No publications provided
| Responsible Party: | : Dr. Kwasi Donyina/Founder and President, GAAD Medical Research Institute Inc. |
| ClinicalTrials.gov Identifier: | NCT00674960 History of Changes |
| Other Study ID Numbers: | GAAD-FD-CTP1 |
| Study First Received: | May 6, 2008 |
| Last Updated: | August 14, 2009 |
| Health Authority: | Canada: Health Canada |
Keywords provided by GAAD Medical Research Institute Inc.:
|
Brain Atrophy, Circumscribed Lobar Circumscribed Lobar Atrophy of the Brain Lobar Atrophy (Brain) |
Pick Disease Pick's Disease Picks Disease of Brain |
Additional relevant MeSH terms:
|
Dementia Pick Disease of the Brain Frontotemporal Dementia Delirium, Dementia, Amnestic, Cognitive Disorders Frontotemporal Lobar Degeneration Aphasia, Primary Progressive Brain Diseases Central Nervous System Diseases Nervous System Diseases Mental Disorders Aphasia |
Speech Disorders Language Disorders Communication Disorders Neurobehavioral Manifestations Neurologic Manifestations Signs and Symptoms TDP-43 Proteinopathies Neurodegenerative Diseases Proteostasis Deficiencies Metabolic Diseases |
ClinicalTrials.gov processed this record on June 17, 2013